Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anuj Bhargava

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Environmental Science & Technology|November 25, 2010
Characterization of lubrication oil emissions from aircraft enginesZhenhong Yu, David S Liscinsky, Edward L Winstead, et al.
Diabetes, Obesity & Metabolism|October 27, 2018
Day-to-day fasting self-monitored blood glucose variability is associated with risk of hypoglycaemia in insulin-treated patients with type 1 and type 2 diabetes: A post hoc analysis of the SWITCH TrialsJ Hans DeVries, Timothy S Bailey, Anuj Bhargava, et al.
The Lancet. Diabetes & Endocrinology|July 17, 2017
Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trialRoy W Beck, Tonya D Riddlesworth, Katrina J Ruedy, et al.
Diabetes Technology & Therapeutics|February 6, 2025
Safety and Effectiveness of MiniMed<sup>TM</sup> 780G Advanced Hybrid Closed-Loop Insulin Intensification in Adults with Insulin-Requiring Type 2 DiabetesAnuj Bhargava, Richard M Bergenstal, Mark L Warren, et al.
Diabetes Care|February 18, 2017
REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 DiabetesGrazia Aleppo, Katrina J Ruedy, Tonya D Riddlesworth, et al.
Diabetes Technology & Therapeutics|May 2, 2024
Multicenter Evaluation of Ultra-Rapid Lispro Insulin with Control-IQ Technology in Adults, Adolescents, and Children with Type 1 DiabetesCarol J Levy, Ryan Bailey, Lori M Laffel, et al.
Pediatric Diabetes|April 30, 2025
Psychosocial Outcomes with the Omnipod® 5 Automated Insulin Delivery System in Children and Adolescents with Type 1 Diabetes and Their CaregiversKorey K Hood, William H Polonsky, Sarah A MacLeish, et al.
JAMA|June 2, 2021
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical TrialThomas Martens, Roy W Beck, Ryan Bailey, et al.
Diabetes Care|September 30, 2021
The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal InsulinGrazia Aleppo, Roy W Beck, Ryan Bailey, et al.
Diabetes Research and Clinical Practice|July 19, 2022
How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 SystemWilliam H Polonsky, Korey K Hood, Carol J Levy, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Environmental Science & Technology|November 25, 2010
Characterization of lubrication oil emissions from aircraft enginesZhenhong Yu, David S Liscinsky, Edward L Winstead, et al.
Diabetes, Obesity & Metabolism|October 27, 2018
Day-to-day fasting self-monitored blood glucose variability is associated with risk of hypoglycaemia in insulin-treated patients with type 1 and type 2 diabetes: A post hoc analysis of the SWITCH TrialsJ Hans DeVries, Timothy S Bailey, Anuj Bhargava, et al.
The Lancet. Diabetes & Endocrinology|July 17, 2017
Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trialRoy W Beck, Tonya D Riddlesworth, Katrina J Ruedy, et al.
Diabetes Technology & Therapeutics|February 6, 2025
Safety and Effectiveness of MiniMed<sup>TM</sup> 780G Advanced Hybrid Closed-Loop Insulin Intensification in Adults with Insulin-Requiring Type 2 DiabetesAnuj Bhargava, Richard M Bergenstal, Mark L Warren, et al.
Diabetes Care|February 18, 2017
REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 DiabetesGrazia Aleppo, Katrina J Ruedy, Tonya D Riddlesworth, et al.
Diabetes Technology & Therapeutics|May 2, 2024
Multicenter Evaluation of Ultra-Rapid Lispro Insulin with Control-IQ Technology in Adults, Adolescents, and Children with Type 1 DiabetesCarol J Levy, Ryan Bailey, Lori M Laffel, et al.
Pediatric Diabetes|April 30, 2025
Psychosocial Outcomes with the Omnipod® 5 Automated Insulin Delivery System in Children and Adolescents with Type 1 Diabetes and Their CaregiversKorey K Hood, William H Polonsky, Sarah A MacLeish, et al.
JAMA|June 2, 2021
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical TrialThomas Martens, Roy W Beck, Ryan Bailey, et al.
Diabetes Care|September 30, 2021
The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal InsulinGrazia Aleppo, Roy W Beck, Ryan Bailey, et al.
Diabetes Research and Clinical Practice|July 19, 2022
How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 SystemWilliam H Polonsky, Korey K Hood, Carol J Levy, et al.
Pageof 5